T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Ane Ogbe, Barbara Kronsteiner, Donal T. Skelly, Matthew Pace, Anthony Brown, Emily Adland, Kareena Adair, Hossain Delowar Akhter, Mohammad Ali, Serat-E Ali, Adrienn Angyal, M. Azim Ansari, Carolina V Arancibia-Cárcamo, Helen Brown, Senthil Chinnakannan, Christopher Conlon, Catherine de Lara, Thushan de Silva, Christina Dold, Tao Dong, Timothy Donnison, David Eyre, Amy Flaxman, Helen Fletcher, Joshua Gardner, James T. Grist, Carl-Philipp Hackstein, Kanoot Jaruthamsophon, Katie Jeffrey, Teresa Lambe, Lian Lee, Wenqin Li, Nicholas Lim, Philippa C. Matthews, Alexander J. Mentzer, Shona C. Moore, Dean J Naisbitt, Monday Ogese, Graham Ogg, Peter Openshaw, Munir Pirmohamed, Andrew J. Pollard, Narayan Ramamurthy, Patpong Rongkard, Sarah Rowland-Jones, Oliver Sampson, Gavin Screaton, Alessandro Sette, Lizzie Stafford, Craig Thompson, Paul J Thomson, Ryan Thwaites, Vinicius Vieira, Daniela Weiskopf, Panagiota Zacharopoulou, Oxford Immunology Network Covid-19 Response T cell Consortium, Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team, Lance Turtle, Paul Klenerman, Philip Goulder, John Frater, Eleanor Barnes, Susanna Dunachie
doi: https://doi.org/10.1101/2020.09.28.20202929

Article Information

doi 
https://doi.org/10.1101/2020.09.28.20202929
History 
  • September 29, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Ane Ogbe1,*,
  2. Barbara Kronsteiner1,2,*,
  3. Donal T. Skelly1,10,17,*,
  4. Matthew Pace1,*,
  5. Anthony Brown1,*,
  6. Emily Adland1,*,
  7. Kareena Adair21,
  8. Hossain Delowar Akhter1,
  9. Mohammad Ali1,2,
  10. Serat-E Ali21,
  11. Adrienn Angyal13,
  12. M. Azim Ansari1,
  13. Carolina V Arancibia-Cárcamo20,4,
  14. Helen Brown1,
  15. Senthil Chinnakannan1,
  16. Christopher Conlon2,10,
  17. Catherine de Lara1,
  18. Thushan de Silva13,
  19. Christina Dold3,4,
  20. Tao Dong11,25,
  21. Timothy Donnison1,
  22. David Eyre10,16,
  23. Amy Flaxman7,
  24. Helen Fletcher9,
  25. Joshua Gardner21,
  26. James T. Grist4,5,6,
  27. Carl-Philipp Hackstein1,
  28. Kanoot Jaruthamsophon21,
  29. Katie Jeffrey10,
  30. Teresa Lambe7,
  31. Lian Lee1,
  32. Wenqin Li1,
  33. Nicholas Lim1,
  34. Philippa C. Matthews1,10,
  35. Alexander J. Mentzer14,10,
  36. Shona C. Moore12,
  37. Dean J Naisbitt21,
  38. Monday Ogese21,
  39. Graham Ogg4,11,10,
  40. Peter Openshaw23,
  41. Munir Pirmohamed21,
  42. Andrew J. Pollard3,4,
  43. Narayan Ramamurthy1,
  44. Patpong Rongkard1,2,8,
  45. Sarah Rowland-Jones13,
  46. Oliver Sampson1,
  47. Gavin Screaton14,
  48. Alessandro Sette15,24,
  49. Lizzie Stafford10,
  50. Craig Thompson18,
  51. Paul J Thomson21,
  52. Ryan Thwaites23,
  53. Vinicius Vieira1,19,
  54. Daniela Weiskopf15,24,
  55. Panagiota Zacharopoulou1,
  56. Oxford Immunology Network Covid-19 Response T cell Consortium†,
  57. Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team†,
  58. Lance Turtle12,22,#,
  59. Paul Klenerman1,4,10,20,#&,
  60. Philip Goulder19,#,
  61. John Frater1,4,10,#,
  62. Eleanor Barnes1,4,10,# and
  63. Susanna Dunachie1,2,8,#
  1. 1Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, UK
  2. 2Centre For Tropical Medicine and Global Health, Nuffield Dept. of Clinical Medicine, University of Oxford, UK
  3. 3Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK
  4. 4NIHR Oxford Biomedical Research Centre, University of Oxford, UK
  5. 5Department of Physiology, Anatomy, and Genetics, University of Oxford, UK
  6. 6Institute of Cancer and Genomic Sciences, University of Birmingham, UK
  7. 7Jenner Institute, University of Oxford, UK
  8. 8Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand
  9. 9Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London Shool of Hygiene and Tropical Medicine, UK
  10. 10Oxford University Hospitals NHS Foundation Trust, Oxford, UK
  11. 11MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, UK
  12. 12HPRU in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, UK
  13. 13The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, UK
  14. 14Wellcome Centre for Human Genetics, University of Oxford, UK
  15. 15Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, CA, USA
  16. 16Big Data Institute, Nuffield Dept. of Population Health, University of Oxford, UK
  17. 17Nuffield Dept of Clinical Neuroscience, University of Oxford, UK
  18. 18Peter Medawar Building for Pathogen Research, Dept of Zoology, University of Oxford, UK
  19. 19Peter Medawar Building for Pathogen Research, Dept of Paediatrics, University of Oxford, UK
  20. 20Translational Gastroenterology Unit, University of Oxford, UK
  21. 21MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, UK
  22. 22Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust, member of Liverpool Health Partners, UK
  23. 23Faculty of Medicine, National heart and lung institute, Imperial College, UK
  24. 24Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, USA
  25. 25Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford, UK
  1. ↵&Corresponding author: Paul Klenerman Paul.klenerman{at}medawar.ox.ac.uk
Back to top
Posted September 29, 2020.
Download PDF

Supplementary Material

Data/Code
Email
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Ane Ogbe, Barbara Kronsteiner, Donal T. Skelly, Matthew Pace, Anthony Brown, Emily Adland, Kareena Adair, Hossain Delowar Akhter, Mohammad Ali, Serat-E Ali, Adrienn Angyal, M. Azim Ansari, Carolina V Arancibia-Cárcamo, Helen Brown, Senthil Chinnakannan, Christopher Conlon, Catherine de Lara, Thushan de Silva, Christina Dold, Tao Dong, Timothy Donnison, David Eyre, Amy Flaxman, Helen Fletcher, Joshua Gardner, James T. Grist, Carl-Philipp Hackstein, Kanoot Jaruthamsophon, Katie Jeffrey, Teresa Lambe, Lian Lee, Wenqin Li, Nicholas Lim, Philippa C. Matthews, Alexander J. Mentzer, Shona C. Moore, Dean J Naisbitt, Monday Ogese, Graham Ogg, Peter Openshaw, Munir Pirmohamed, Andrew J. Pollard, Narayan Ramamurthy, Patpong Rongkard, Sarah Rowland-Jones, Oliver Sampson, Gavin Screaton, Alessandro Sette, Lizzie Stafford, Craig Thompson, Paul J Thomson, Ryan Thwaites, Vinicius Vieira, Daniela Weiskopf, Panagiota Zacharopoulou, Oxford Immunology Network Covid-19 Response T cell Consortium, Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team, Lance Turtle, Paul Klenerman, Philip Goulder, John Frater, Eleanor Barnes, Susanna Dunachie
medRxiv 2020.09.28.20202929; doi: https://doi.org/10.1101/2020.09.28.20202929
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area